{"organizations": [], "uuid": "3cbd0a97d604e4733e8bec5878c78b6a3b96dec4", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-the-medicines-co-reports-q1-gaap-l/brief-the-medicines-co-reports-q1-gaap-loss-per-share-1-14-from-continuing-operations-idUSASC09X9C", "country": "US", "domain_rank": 408, "title": "BRIEF-The Medicines Co Reports Q1 GAAP Loss Per Share $1.14 From Continuing Operations", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-25T14:07:00.000+03:00", "replies_count": 0, "uuid": "3cbd0a97d604e4733e8bec5878c78b6a3b96dec4"}, "author": "", "url": "https://www.reuters.com/article/brief-the-medicines-co-reports-q1-gaap-l/brief-the-medicines-co-reports-q1-gaap-loss-per-share-1-14-from-continuing-operations-idUSASC09X9C", "ord_in_thread": 0, "title": "BRIEF-The Medicines Co Reports Q1 GAAP Loss Per Share $1.14 From Continuing Operations", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-the medicines co reports", "sentiment": "negative"}, {"name": "operations reuters staff    medicines co", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 25 (Reuters) - Medicines Co:\n* THE MEDICINES COMPANY REPORTS FIRST-QUARTER 2018 RESULTS\n* Q1 GAAP LOSS PER SHARE $1.14 FROM CONTINUING OPERATIONS * Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.76 FROM CONTINUING OPERATIONS\n* Q1 EARNINGS PER SHARE VIEW $-0.78 â€” THOMSON REUTERS I/B/E/S\n* QUARTERLY NET REVENUES $7.8 MILLION VERSUS $17.5 MILLION Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-04-25T14:07:00.000+03:00", "crawled": "2018-04-25T14:21:45.017+03:00", "highlightTitle": ""}